Loading...

Tetra Bio-Pharma Inc.

TBP.TO•TSX
HealthcareBiotechnology
$0.03
$0.00(0.00%)

Tetra Bio-Pharma Inc. (TBP.TO) Stock Overview

Explore Tetra Bio-Pharma Inc.’s financial performance, market position, analyst ratings, and future outlook.

Stats data is not available for TBP.TOStats details for TBP.TO are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for TBP.TOAnalyst Recommendations details for TBP.TO are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Tetra Bio-Pharma Inc., a biopharmaceutical company, engages in the discovery and development of cannabinoid-derived drugs for inflammation, pain, ophthalmology, and oncology. The company develops PLENITUDE to treat cancer-related pain in advanced cancer patients; REBORN for the treatment of breakthrough cancer pain; Reduvo for chemotherapy-induced nausea and vomiting; ARDS-003 for the treatment of sepsis and prevention of acute respiratory distress syndrome; and SERENITY to treat cancer cachexia. It also develops PPP003 for painful dry eye and uveitis pain; and HCC011 for hepatocellular carcinoma. The company is headquartered in Orléans, Canada.

CEO

Dr. Guy Chamberland M.Sc., Master Herbal

Employees

33

Headquarters

2316 St. Joseph Boulevard, Orléans, ON

Founded

2018

Frequently Asked Questions